Quarterly report · Q2
9438.TEDINET S100QQRZ
Period2022-10-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Amended by S100SBOM (2023-11-20).
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥13.6bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥26.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.0bn | 2021-10-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | −¥19m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥599m | 2021-10-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥187m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥486m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥293m | 2021-10-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥291m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥363m | 2021-10-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥326m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥930m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥123m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥401m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥4m | 2021-10-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥28.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥29.3bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥29.2bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.8bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥17.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥17.9bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥19.2bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥12.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥12.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.1bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.5bn | at 2021-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.1bn | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.4bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥788m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥616m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.5bn | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥798m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥344m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥776m | 2021-10-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-5.95 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.82 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-16.99 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.36 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥2.25 | 2021-10-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 46.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2023-03-31 | −¥858m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥858m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥1.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥9.5bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥9.3bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥153m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥2.8bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥2.2bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥5m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥220m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥2.4bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥1.7bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥699m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥807m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥309m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥461m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥14.5bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥13.6bn |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | ¥858m |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥1.3bn |
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-03-31 | −¥646m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-03-31 | −¥1.2bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥9.1bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥9.0bn |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥112m |
| jpcrp040300-q2r_E05049-000Content Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | ¥2.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥1.9bn |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥10m |
| jpcrp040300-q2r_E05049-000Healthcare Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥649m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥2.5bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥2.0bn |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥524m |
| jpcrp040300-q2r_E05049-000Other Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥176m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | revenue external | 2021-10-01 → 2022-03-31 | ¥121m |
| jpcrp040300-q2r_E05049-000School DX Businessreportable segment | segment profit | 2021-10-01 → 2022-03-31 | −¥233m |
| —segment total | revenue | 2021-10-01 → 2022-03-31 | ¥13.6bn |
| —segment total | revenue external | 2021-10-01 → 2022-03-31 | ¥13.0bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-03-31 | ¥646m |
| —segment total | segment profit | 2021-10-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 540
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentQuarterInstant_No1MajorShareholdersMember | 11875700 | |
| Shareholding ratio | CurrentQuarterInstant_No1MajorShareholdersMember | 0.2157 | |
| Number of shares held | CurrentQuarterInstant_No2MajorShareholdersMember | 10096000 | |
| Shareholding ratio | CurrentQuarterInstant_No2MajorShareholdersMember | 0.1834 | |
| Number of shares held | CurrentQuarterInstant_No3MajorShareholdersMember | 5358800 | |
| Shareholding ratio | CurrentQuarterInstant_No3MajorShareholdersMember | 0.0973 | |
| Number of shares held | CurrentQuarterInstant_No4MajorShareholdersMember | 4127000 | |
| Shareholding ratio | CurrentQuarterInstant_No4MajorShareholdersMember | 0.0750 | |
| Number of shares held | CurrentQuarterInstant_No5MajorShareholdersMember | 4062200 | |
| Shareholding ratio | CurrentQuarterInstant_No5MajorShareholdersMember | 0.0738 | |
| Number of shares held | CurrentQuarterInstant_No6MajorShareholdersMember | 3915400 | |
| Shareholding ratio | CurrentQuarterInstant_No6MajorShareholdersMember | 0.0711 | |
| Number of shares held | CurrentQuarterInstant_No7MajorShareholdersMember | 3150000 | |
| Shareholding ratio | CurrentQuarterInstant_No7MajorShareholdersMember | 0.0572 | |
| Number of shares held | CurrentQuarterInstant_No8MajorShareholdersMember | 1986500 | |
| Shareholding ratio | CurrentQuarterInstant_No8MajorShareholdersMember | 0.0361 | |
| Number of shares held | CurrentQuarterInstant_No9MajorShareholdersMember | 1000000 | |
| Shareholding ratio | CurrentQuarterInstant_No9MajorShareholdersMember | 0.0182 | |
| Number of shares held | CurrentQuarterInstant_No10MajorShareholdersMember | 672000 | |
| Shareholding ratio | CurrentQuarterInstant_No10MajorShareholdersMember | 0.0122 | |
| Number of shares held | CurrentQuarterInstant | 46243600 | |
| Shareholding ratio | CurrentQuarterInstant | 0.8398 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 6200700 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember | 672000 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 54384800 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 543848 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 5500 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 61263000 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 543848 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 6200700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 6200700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.1012 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row2Member | 672000 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row2Member | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row2Member | 672000 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row2Member | 0.0110 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 6872700 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | － | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 6872700 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.1122 | |
| Cash and deposits | Prior1YearInstant | 12097658000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 12763647000 | JPY |
| Notes and accounts receivable trade and contract assets | Prior1YearInstant | 4294825000 | JPY |
| Notes and accounts receivable trade and contract assets | CurrentQuarterInstant | 4512835000 | JPY |
| Other ca | Prior1YearInstant | 2420195000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |